53 related articles for article (PubMed ID: 3775002)
1. [Increasing the radioresistance of normal tissue using hypoxia in the radiotherapy of breast cancer].
Cyb AF; Mardynsky JuS ; Strelcov RB
Radiobiol Radiother (Berl); 1986; 27(4):447-50. PubMed ID: 3775002
[No Abstract] [Full Text] [Related]
2. High dose daily amifostine and hypofractionated intensively accelerated radiotherapy for locally advanced breast cancer. A phase I/II study and report on early and late sequellae.
Koukourakis MI; Yannakakis D
Anticancer Res; 2001; 21(4B):2973-8. PubMed ID: 11712796
[TBL] [Abstract][Full Text] [Related]
3. [The immediate and late results of protecting the patient's normal tissues by using the gas hypoxic mixture GHM-10 in the radiation therapy of breast cancer].
Strelkov RB; Mardynskiĭ IuS; Zakoshchikov KF; Firsova PP
Vopr Onkol; 1985; 31(12):35-9. PubMed ID: 4082505
[TBL] [Abstract][Full Text] [Related]
4. Thêta-Cream versus Bepanthol lotion in breast cancer patients under radiotherapy. A new prophylactic agent in skin care?
Röper B; Kaisig D; Auer F; Mergen E; Molls M
Strahlenther Onkol; 2004 May; 180(5):315-22. PubMed ID: 15127162
[TBL] [Abstract][Full Text] [Related]
5. Amifostine induces anaerobic metabolism and hypoxia-inducible factor 1 alpha.
Koukourakis MI; Giatromanolaki A; Chong W; Simopoulos C; Polychronidis A; Sivridis E; Harris AL
Cancer Chemother Pharmacol; 2004 Jan; 53(1):8-14. PubMed ID: 14574457
[TBL] [Abstract][Full Text] [Related]
6. Predictive factors for late normal tissue complications following radiotherapy for breast cancer.
Lilla C; Ambrosone CB; Kropp S; Helmbold I; Schmezer P; von Fournier D; Haase W; Sautter-Bihl ML; Wenz F; Chang-Claude J
Breast Cancer Res Treat; 2007 Nov; 106(1):143-50. PubMed ID: 17221151
[TBL] [Abstract][Full Text] [Related]
7. Hypofractionated and accelerated radiotherapy with subcutaneous amifostine cytoprotection as short adjuvant regimen after breast-conserving surgery: interim report.
Koukourakis MI; Tsoutsou PG; Abatzoglou IM; Sismanidou K; Giatromanolaki A; Sivridis E
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1173-80. PubMed ID: 19058920
[TBL] [Abstract][Full Text] [Related]
8. Crux medicorum ulcerated radiation-induced fibrosis - successful therapy with pentoxifylline and vitamin E.
Fischer M; Wohlrab J; Marsch W
Eur J Dermatol; 2001; 11(1):38-40. PubMed ID: 11174136
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of dose-response models and parameters predicting radiation induced pneumonitis using clinical data from breast cancer radiotherapy.
Tsougos I; Mavroidis P; Rajala J; Theodorou K; Järvenpää R; Pitkänen MA; Holli K; Ojala AT; Lind BK; Hyödynmaa S; Kappas C
Phys Med Biol; 2005 Aug; 50(15):3535-54. PubMed ID: 16030381
[TBL] [Abstract][Full Text] [Related]
10. [Late lesion of the lung tissue following radiotherapy of breast cancer].
Guzecki A
Pol Przegl Radiol Med Nukl; 1971; 35(6):723-30. PubMed ID: 5142200
[No Abstract] [Full Text] [Related]
11. [Prevention and therapy of radiodermatitis in postoperative radiotherapy following mastectomy].
Kastratović M; Rödl W
Fortschr Med; 1971 Aug; 89(22):889-90. PubMed ID: 5154177
[No Abstract] [Full Text] [Related]
12. Radiation dose and risk of soft tissue and bone sarcoma after breast cancer treatment.
Rubino C; Shamsaldin A; Lê MG; Labbé M; Guinebretière JM; Chavaudra J; de Vathaire F
Breast Cancer Res Treat; 2005 Feb; 89(3):277-88. PubMed ID: 15754127
[TBL] [Abstract][Full Text] [Related]
13. [Radiobiological limits in conventional after-irradiation of breast cancer. II. Observations on soft tissue changes].
van der Wall H
Radiobiol Radiother (Berl); 1984; 25(4):607-13. PubMed ID: 6505180
[No Abstract] [Full Text] [Related]
14. Hypofractionated and accelerated radiotherapy with amifostine cytoprotection (HypoARC): a new concept in radiotherapy and encouraging results in breast cancer.
Koukourakis MI
Semin Oncol; 2002 Dec; 29(6 Suppl 19):42-6. PubMed ID: 12577243
[TBL] [Abstract][Full Text] [Related]
15. Radioprotective effect of moderate wine consumption in patients with breast carcinoma.
Morganti AG; Digesù C; Panunzi S; De Gaetano A; Macchia G; Deodato F; Cece MG; Cirocco M; Di Castelnuovo A; Iacoviello L; Valentini V; Cellini N; de Gaetano G
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1501-5. PubMed ID: 19395196
[TBL] [Abstract][Full Text] [Related]
16. [Radiation biological limits in the conventional postirradiation of breast cancer].
van der Wall H
Radiobiol Radiother (Berl); 1982; 23(4):357-68. PubMed ID: 7146355
[No Abstract] [Full Text] [Related]
17. Pentoxifylline and vitamin E treatment for prevention of radiation-induced side-effects in women with breast cancer: a phase two, double-blind, placebo-controlled randomised clinical trial (Ptx-5).
Magnusson M; Höglund P; Johansson K; Jönsson C; Killander F; Malmström P; Weddig A; Kjellén E
Eur J Cancer; 2009 Sep; 45(14):2488-95. PubMed ID: 19540105
[TBL] [Abstract][Full Text] [Related]
18. Increased proliferative activity and p53 expression in normal glandular breast tissue after radiation therapy.
Poeze M; von Meyenfeldt MF; Peterse JL; George WD; de Jong JM; Jager JJ; Thunnissen FB
J Pathol; 1998 May; 185(1):32-7. PubMed ID: 9713357
[TBL] [Abstract][Full Text] [Related]
19. [Preoperative radiotherapy in breast cancer].
Datsenko VS
Med Radiol (Mosk); 1973 Nov; 18(11):23-30. PubMed ID: 4786057
[No Abstract] [Full Text] [Related]
20. [Radiation-induced sarcomas after breast cancer: experience of Institute Curie and review of literature].
Kirova Y; Vilcoq JR; Asselain B; Sastre-Garau X; Campana F; Dendale R; Bollet M; Fourquet A
Cancer Radiother; 2006; 10(1-2):83-90. PubMed ID: 16300982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
